>AT1G17880.1 | nascent polypeptide-associated complex (NAC) domain-containing protein / BTF3b-like transcription factor putative
MNREKLMKMANTVRTGGKGTVRRKKKAVHKTNTTDDKRLQSTLKRIGVNSIPAIEEVNIF
KDDVVIQFINPKVQASIAANTWVVSGSPQTKKLQDILPQIISQLGPDNMDNLKKLAEQFQ
KQASGEGNAASATIQEEDDDDVPELVGETFETAAEEKAPAAAASS*
>AT5G35620.2 | LSP1 (LOSS OF SUSCEPTIBILITY TO POTYVIRUS 1) RNA 7-methylguanosine cap binding / RNA binding / translation initiation factor
MATDDVNEPLPAAAELPATEAEKQPHKLERKWSFWFDNQSKKGAAWGASLRKAYTFDTVE
DFWGLHETIFQTSKLTANAEIHLFKAGVEPKWEDPECANGGKWTWVVTANRKEALDKGWL
ETLMALIGEQFDEADEICGVVASVRPQSKQDKLSLWTRTKSNEAVLV*
>AT5G35620.2 | LSP1 (LOSS OF SUSCEPTIBILITY TO POTYVIRUS 1) RNA 7-methylguanosine cap binding / RNA binding / translation initiation factor
MATDDVNEPLPAAAELPATEAEKQPHKLERKWSFWFDNQSKKGAAWGASLRKAYTFDTVE
DFWGLHETIFQTSKLTANAEIHLFKAGVEPKWEDPECANGGKWTWVVTANRKEALDKGWL
ETLMALIGEQFDEADEICGVVASVRPQSKQDKLSLWTRTKSNEAVLV*
>AT5G35620.1 | LSP1 (LOSS OF SUSCEPTIBILITY TO POTYVIRUS 1) RNA 7-methylguanosine cap binding / RNA binding / translation initiation factor
MATDDVNEPLPAAAELPATEAEKQPHKLERKWSFWFDNQSKKGAAWGASLRKAYTFDTVE
DFWGLHETIFQTSKLTANAEIHLFKAGVEPKWEDPECANGGKWTWVVTANRKEALDKGWL
ETLMALIGEQFDEADEICGVVASVRPQSKQDKLSLWTRTKSNEAVLMGIGKKWKEILDVT
DKITFNNHDDSRRSRFTV*
>AT5G35620.1 | LSP1 (LOSS OF SUSCEPTIBILITY TO POTYVIRUS 1) RNA 7-methylguanosine cap binding / RNA binding / translation initiation factor
MATDDVNEPLPAAAELPATEAEKQPHKLERKWSFWFDNQSKKGAAWGASLRKAYTFDTVE
DFWGLHETIFQTSKLTANAEIHLFKAGVEPKWEDPECANGGKWTWVVTANRKEALDKGWL
ETLMALIGEQFDEADEICGVVASVRPQSKQDKLSLWTRTKSNEAVLMGIGKKWKEILDVT
DKITFNNHDDSRRSRFTV*
>AT5G18410.1 | PIR121 transcription activator
MAVPVEEAIAALSTFSLEDEQPEVQGPAVMVSAERAATDSPIEYSDVAAYRLSLSEDTKA
LNQLNTLIQEGKEMASILYTYRSCVKALPQLPESMKHSQADLYLETYQVLDLEMSRLREI
QRWQSSASAKLAADMQRFSRPERRINGPTVTHLWSMLKLLDVLVQLDHLKNAKASIPNDF
SWYKRTFTQVSAQWQDTDTMREELDDLQIFLSTRWAILLNLHVEMFRVNNVEDILQVLIV
FIVESLELDFALLFPERYILLRVLPVLVVLATPSEKDTEALYKRVKLNRLINIFKNDPVI
PAFPDLHLSPAAILKELSVYFQKFSSQTRLLTLPAPHELPPREALEYQRHYLIVNHIGAL
RAEHDDFTIRFASSMNQLLLLKSNDGAYTEWCREVKGNMYDMVVEGFQLLSRWTARIWEQ
CAWKFSRPCRDAGETPEASGSYSDYEKVVRFNYTAEERKALVELVGYIKSVGSMLQRCDT
LVADALWETIHAEVQDFVQNTLATMLRTTFRKKKDLSRILSDMRTLSADWMANTRPEHEM
PSSQHGNDESRGNFFYPRPVAPTAAQVHCLQFLIYEVVSGGNLRRPGGFFGNNGSEIPVN
DLKQLETFFYKLSFFLHILDYSASIGILTDLGFLWFREFYLESSRVIQFPIECSLPWMLI
DYILEAQNSGLLESVLLPFDIYNDSAQQALVVLRQRFLYDEIEAEVDHGFDIFVSRLSES
IFTYYKSWSASELLDPSFLFALDNGEKFSIQPVRFTALFKMTKVKILGRTINLRSLIAQR
MNRIFRENLEFLFDRFESQDLCAVVELEKLIDILKHSHELLSQDLSIDPFSLMLNEMQEN
ISLVSFSSRLATQIWSEMQSDFLPNFILCNTTQRFVRSSKVPPTQKPSVPSAKPSFYCGT
QDLNAAHQSFARLHSGFFGIPHLFSIVKLLGSRSLPWLIRALLDHISNKITTLEPMISGL
QEALPKSIGLLSFDGGVTGCMKLIREQLNWGTKSELKSEVLRGIKEIGSVIYTMGLLDIV
LVSPVDTKRFMQTAPWLGLIPGAEGQIVNAQDGESPLVNLLKSATSAVVSSPGCLNPAAF
YTMSKQAEAADLLYKANMNGGSVLEYTLAFTSASLDKYCSKWSAPPKTGFVDITTSKDFY
RIYGGLQIGYLEEITAPQSAQHEVLGDSIAWGGCTIIYLLGQQLHFELFDFSYQVLNVSE
VETVSASHTHRNPQIHQGWEGLLEGMKKARRLNNHVFSMLKARCPLEDKTACAIKQSGAP
LPRVRFENTVSAFETLPQKGTVG*
>AT5G18410.1 | PIR121 transcription activator
MAVPVEEAIAALSTFSLEDEQPEVQGPAVMVSAERAATDSPIEYSDVAAYRLSLSEDTKA
LNQLNTLIQEGKEMASILYTYRSCVKALPQLPESMKHSQADLYLETYQVLDLEMSRLREI
QRWQSSASAKLAADMQRFSRPERRINGPTVTHLWSMLKLLDVLVQLDHLKNAKASIPNDF
SWYKRTFTQVSAQWQDTDTMREELDDLQIFLSTRWAILLNLHVEMFRVNNVEDILQVLIV
FIVESLELDFALLFPERYILLRVLPVLVVLATPSEKDTEALYKRVKLNRLINIFKNDPVI
PAFPDLHLSPAAILKELSVYFQKFSSQTRLLTLPAPHELPPREALEYQRHYLIVNHIGAL
RAEHDDFTIRFASSMNQLLLLKSNDGAYTEWCREVKGNMYDMVVEGFQLLSRWTARIWEQ
CAWKFSRPCRDAGETPEASGSYSDYEKVVRFNYTAEERKALVELVGYIKSVGSMLQRCDT
LVADALWETIHAEVQDFVQNTLATMLRTTFRKKKDLSRILSDMRTLSADWMANTRPEHEM
PSSQHGNDESRGNFFYPRPVAPTAAQVHCLQFLIYEVVSGGNLRRPGGFFGNNGSEIPVN
DLKQLETFFYKLSFFLHILDYSASIGILTDLGFLWFREFYLESSRVIQFPIECSLPWMLI
DYILEAQNSGLLESVLLPFDIYNDSAQQALVVLRQRFLYDEIEAEVDHGFDIFVSRLSES
IFTYYKSWSASELLDPSFLFALDNGEKFSIQPVRFTALFKMTKVKILGRTINLRSLIAQR
MNRIFRENLEFLFDRFESQDLCAVVELEKLIDILKHSHELLSQDLSIDPFSLMLNEMQEN
ISLVSFSSRLATQIWSEMQSDFLPNFILCNTTQRFVRSSKVPPTQKPSVPSAKPSFYCGT
QDLNAAHQSFARLHSGFFGIPHLFSIVKLLGSRSLPWLIRALLDHISNKITTLEPMISGL
QEALPKSIGLLSFDGGVTGCMKLIREQLNWGTKSELKSEVLRGIKEIGSVIYTMGLLDIV
LVSPVDTKRFMQTAPWLGLIPGAEGQIVNAQDGESPLVNLLKSATSAVVSSPGCLNPAAF
YTMSKQAEAADLLYKANMNGGSVLEYTLAFTSASLDKYCSKWSAPPKTGFVDITTSKDFY
RIYGGLQIGYLEEITAPQSAQHEVLGDSIAWGGCTIIYLLGQQLHFELFDFSYQVLNVSE
VETVSASHTHRNPQIHQGWEGLLEGMKKARRLNNHVFSMLKARCPLEDKTACAIKQSGAP
LPRVRFENTVSAFETLPQKGTVG*
>AT5G18410.1 | PIR121 transcription activator
MAVPVEEAIAALSTFSLEDEQPEVQGPAVMVSAERAATDSPIEYSDVAAYRLSLSEDTKA
LNQLNTLIQEGKEMASILYTYRSCVKALPQLPESMKHSQADLYLETYQVLDLEMSRLREI
QRWQSSASAKLAADMQRFSRPERRINGPTVTHLWSMLKLLDVLVQLDHLKNAKASIPNDF
SWYKRTFTQVSAQWQDTDTMREELDDLQIFLSTRWAILLNLHVEMFRVNNVEDILQVLIV
FIVESLELDFALLFPERYILLRVLPVLVVLATPSEKDTEALYKRVKLNRLINIFKNDPVI
PAFPDLHLSPAAILKELSVYFQKFSSQTRLLTLPAPHELPPREALEYQRHYLIVNHIGAL
RAEHDDFTIRFASSMNQLLLLKSNDGAYTEWCREVKGNMYDMVVEGFQLLSRWTARIWEQ
CAWKFSRPCRDAGETPEASGSYSDYEKVVRFNYTAEERKALVELVGYIKSVGSMLQRCDT
LVADALWETIHAEVQDFVQNTLATMLRTTFRKKKDLSRILSDMRTLSADWMANTRPEHEM
PSSQHGNDESRGNFFYPRPVAPTAAQVHCLQFLIYEVVSGGNLRRPGGFFGNNGSEIPVN
DLKQLETFFYKLSFFLHILDYSASIGILTDLGFLWFREFYLESSRVIQFPIECSLPWMLI
DYILEAQNSGLLESVLLPFDIYNDSAQQALVVLRQRFLYDEIEAEVDHGFDIFVSRLSES
IFTYYKSWSASELLDPSFLFALDNGEKFSIQPVRFTALFKMTKVKILGRTINLRSLIAQR
MNRIFRENLEFLFDRFESQDLCAVVELEKLIDILKHSHELLSQDLSIDPFSLMLNEMQEN
ISLVSFSSRLATQIWSEMQSDFLPNFILCNTTQRFVRSSKVPPTQKPSVPSAKPSFYCGT
QDLNAAHQSFARLHSGFFGIPHLFSIVKLLGSRSLPWLIRALLDHISNKITTLEPMISGL
QEALPKSIGLLSFDGGVTGCMKLIREQLNWGTKSELKSEVLRGIKEIGSVIYTMGLLDIV
LVSPVDTKRFMQTAPWLGLIPGAEGQIVNAQDGESPLVNLLKSATSAVVSSPGCLNPAAF
YTMSKQAEAADLLYKANMNGGSVLEYTLAFTSASLDKYCSKWSAPPKTGFVDITTSKDFY
RIYGGLQIGYLEEITAPQSAQHEVLGDSIAWGGCTIIYLLGQQLHFELFDFSYQVLNVSE
VETVSASHTHRNPQIHQGWEGLLEGMKKARRLNNHVFSMLKARCPLEDKTACAIKQSGAP
LPRVRFENTVSAFETLPQKGTVG*
>AT5G18410.2 | PIR121 transcription activator
MAVPVEEAIAALSTFSLEDEQPEVQGPAVMVSAERAATDSPIEYSDVAAYRLSLSEDTKA
LNQLNTLIQEGKEMASILYTYRSCVKALPQLPESMKHSQADLYLETYQVLDLEMSRLREI
QRWQSSASAKLAADMQRFSRPERRINGPTVTHLWSMLKLLDVLVQLDHLKNAKASIPNDF
SWYKRTFTQVSAQWQDTDTMREELDDLQIFLSTRWAILLNLHVEMFRVNNVEDILQVLIV
FIVESLELDFALLFPERYILLRVLPVLVVLATPSEKDTEALYKRVKLNRLINIFKNDPVI
PAFPDLHLSPAAILKELSVYFQKFSSQTRLLTLPAPHELPPREALEYQRHYLIVNHIGAL
RAEHDDFTIRFASSMNQLLLLKSNDGAYTEWCREVKGNMYDMVVEGFQLLSRWTARIWEQ
CAWKFSRPCRDAGETPEASGSYSDYEKVVRFNYTAEERKALVELVGYIKSVGSMLQRCDT
LVADALWETIHAEVQDFVQNTLATMLRTTFRKKKDLSRILSDMRTLSADWMANTRPEHEM
PSSQHGNDESRGNFFYPRPVAPTAAQVHCLQFLIYEVVSGGNLRRPGGFFGNNGSEIPVN
DLKQLETFFYKLSFFLHILDYSASIGILTDLGFLWFREFYLESSRVIQFPIECSLPWMLI
DYILEAQNSGLLESVLLPFDIYNDSAQQALVVLRQRFLYDEIEAEVDHGFDIFVSRLSES
IFTYYKSWSASELLDPSFLFALDNGEKFSIQPVRFTALFKMTKVKILGRTINLRSLIAQR
MNRIFRENLEFLFDRFESQDLCAVVELEKLIDILKHSHELLSQDLSIDPFSLMLNEMQEN
ISLVSFSSRLATQIWSEMQSDFLPNFILCNTTQRFVRSSKVPPTQKPSVPSAKPSFYCGT
QDLNAAHQSFARLHSGFFGIPHLFSIVKLLGSRSLPWLIRALLDHISNKITTLEPMISGL
QEALPKSIGLLSFDGGVTGCMKLIREQLNWGTKSELKSEVLRGIKEIGSVIYTMGLLDIV
LREVDTKRFMQTAPWLGLIPGAEGQIVNAQDGESPLVNLLKSATSAVVSSPGCLNPAAFY
TMSKQAEAADLLYKANMNGGSVLEYTLAFTSASLDKYCSKWSAPPKTGFVDITTSKDFYR
IYGGLQIGYLEEITAPQSAQHEVLGDSIAWGGCTIIYLLGQQLHFELFDFSYQVLNVSEV
ETVSASHTHRNPQIHQGWEGLLEGMKKARRLNNHVFSMLKARCPLEDKTACAIKQSGAPL
PRVRFENTVSAFETLPQKGTVG*
>AT5G18410.2 | PIR121 transcription activator
MAVPVEEAIAALSTFSLEDEQPEVQGPAVMVSAERAATDSPIEYSDVAAYRLSLSEDTKA
LNQLNTLIQEGKEMASILYTYRSCVKALPQLPESMKHSQADLYLETYQVLDLEMSRLREI
QRWQSSASAKLAADMQRFSRPERRINGPTVTHLWSMLKLLDVLVQLDHLKNAKASIPNDF
SWYKRTFTQVSAQWQDTDTMREELDDLQIFLSTRWAILLNLHVEMFRVNNVEDILQVLIV
FIVESLELDFALLFPERYILLRVLPVLVVLATPSEKDTEALYKRVKLNRLINIFKNDPVI
PAFPDLHLSPAAILKELSVYFQKFSSQTRLLTLPAPHELPPREALEYQRHYLIVNHIGAL
RAEHDDFTIRFASSMNQLLLLKSNDGAYTEWCREVKGNMYDMVVEGFQLLSRWTARIWEQ
CAWKFSRPCRDAGETPEASGSYSDYEKVVRFNYTAEERKALVELVGYIKSVGSMLQRCDT
LVADALWETIHAEVQDFVQNTLATMLRTTFRKKKDLSRILSDMRTLSADWMANTRPEHEM
PSSQHGNDESRGNFFYPRPVAPTAAQVHCLQFLIYEVVSGGNLRRPGGFFGNNGSEIPVN
DLKQLETFFYKLSFFLHILDYSASIGILTDLGFLWFREFYLESSRVIQFPIECSLPWMLI
DYILEAQNSGLLESVLLPFDIYNDSAQQALVVLRQRFLYDEIEAEVDHGFDIFVSRLSES
IFTYYKSWSASELLDPSFLFALDNGEKFSIQPVRFTALFKMTKVKILGRTINLRSLIAQR
MNRIFRENLEFLFDRFESQDLCAVVELEKLIDILKHSHELLSQDLSIDPFSLMLNEMQEN
ISLVSFSSRLATQIWSEMQSDFLPNFILCNTTQRFVRSSKVPPTQKPSVPSAKPSFYCGT
QDLNAAHQSFARLHSGFFGIPHLFSIVKLLGSRSLPWLIRALLDHISNKITTLEPMISGL
QEALPKSIGLLSFDGGVTGCMKLIREQLNWGTKSELKSEVLRGIKEIGSVIYTMGLLDIV
LREVDTKRFMQTAPWLGLIPGAEGQIVNAQDGESPLVNLLKSATSAVVSSPGCLNPAAFY
TMSKQAEAADLLYKANMNGGSVLEYTLAFTSASLDKYCSKWSAPPKTGFVDITTSKDFYR
IYGGLQIGYLEEITAPQSAQHEVLGDSIAWGGCTIIYLLGQQLHFELFDFSYQVLNVSEV
ETVSASHTHRNPQIHQGWEGLLEGMKKARRLNNHVFSMLKARCPLEDKTACAIKQSGAPL
PRVRFENTVSAFETLPQKGTVG*
>AT5G18410.2 | PIR121 transcription activator
MAVPVEEAIAALSTFSLEDEQPEVQGPAVMVSAERAATDSPIEYSDVAAYRLSLSEDTKA
LNQLNTLIQEGKEMASILYTYRSCVKALPQLPESMKHSQADLYLETYQVLDLEMSRLREI
QRWQSSASAKLAADMQRFSRPERRINGPTVTHLWSMLKLLDVLVQLDHLKNAKASIPNDF
SWYKRTFTQVSAQWQDTDTMREELDDLQIFLSTRWAILLNLHVEMFRVNNVEDILQVLIV
FIVESLELDFALLFPERYILLRVLPVLVVLATPSEKDTEALYKRVKLNRLINIFKNDPVI
PAFPDLHLSPAAILKELSVYFQKFSSQTRLLTLPAPHELPPREALEYQRHYLIVNHIGAL
RAEHDDFTIRFASSMNQLLLLKSNDGAYTEWCREVKGNMYDMVVEGFQLLSRWTARIWEQ
CAWKFSRPCRDAGETPEASGSYSDYEKVVRFNYTAEERKALVELVGYIKSVGSMLQRCDT
LVADALWETIHAEVQDFVQNTLATMLRTTFRKKKDLSRILSDMRTLSADWMANTRPEHEM
PSSQHGNDESRGNFFYPRPVAPTAAQVHCLQFLIYEVVSGGNLRRPGGFFGNNGSEIPVN
DLKQLETFFYKLSFFLHILDYSASIGILTDLGFLWFREFYLESSRVIQFPIECSLPWMLI
DYILEAQNSGLLESVLLPFDIYNDSAQQALVVLRQRFLYDEIEAEVDHGFDIFVSRLSES
IFTYYKSWSASELLDPSFLFALDNGEKFSIQPVRFTALFKMTKVKILGRTINLRSLIAQR
MNRIFRENLEFLFDRFESQDLCAVVELEKLIDILKHSHELLSQDLSIDPFSLMLNEMQEN
ISLVSFSSRLATQIWSEMQSDFLPNFILCNTTQRFVRSSKVPPTQKPSVPSAKPSFYCGT
QDLNAAHQSFARLHSGFFGIPHLFSIVKLLGSRSLPWLIRALLDHISNKITTLEPMISGL
QEALPKSIGLLSFDGGVTGCMKLIREQLNWGTKSELKSEVLRGIKEIGSVIYTMGLLDIV
LREVDTKRFMQTAPWLGLIPGAEGQIVNAQDGESPLVNLLKSATSAVVSSPGCLNPAAFY
TMSKQAEAADLLYKANMNGGSVLEYTLAFTSASLDKYCSKWSAPPKTGFVDITTSKDFYR
IYGGLQIGYLEEITAPQSAQHEVLGDSIAWGGCTIIYLLGQQLHFELFDFSYQVLNVSEV
ETVSASHTHRNPQIHQGWEGLLEGMKKARRLNNHVFSMLKARCPLEDKTACAIKQSGAPL
PRVRFENTVSAFETLPQKGTVG*
>AT5G18410.3 | PIR121 transcription activator
MAVPVEEAIAALSTFSLEDEQPEVQGPAVMVSAERAATDSPIEYSDVAAYRLSLSEDTKA
LNQLNTLIQEGKEMASILYTYRSCVKALPQLPESMKHSQADLYLETYQVLDLEMSRLREI
QRWQSSASAKLAADMQRFSRPERRINGPTVTHLWSMLKLLDVLVQLDHLKNAKASIPNDF
SWYKRTFTQVSAQWQDTDTMREELDDLQIFLSTRWAILLNLHVEMFRVNNVEDILQVLIV
FIVESLELDFALLFPERYILLRVLPVLVVLATPSEKDTEALYKRVKLNRLINIFKNDPVI
PAFPDLHLSPAAILKELSVYFQKFSSQTRLLTLPAPHELPPREALEYQRHYLIVNHIGAL
RAEHDDFTIRFASSMNQLLLLKSNDGAYTEWCREVKGNMYDMVVEGFQLLSRWTARIWEQ
CAWKFSRPCRDAGETPEASGSYSDYEKVVRFNYTAEERKALVELVGYIKSVGSMLQRCDT
LVADALWETIHAEVQDFVQNTLATMLRTTFRKKKDLSRILSDMRTLSADWMANTRPEHEM
PSSQHGNDESRGNFFYPRPVAPTAAQVHCLQFLIYEVVSGGNLRRPGGFFGNNGSEIPVN
DLKQLETFFYKLSFFLHILDYSASIGILTDLGFLWFREFYLESSRVIQFPIECSLPWMLI
DYILEAQNSGLLESVLLPFDIYNDSAQQALVVLRQRFLYDEIEAEVDHGFDIFVSRLSES
IFTYYKSWSASELLDPSFLFALDNGEKFSIQPVRFTALFKMTKVKILGRTINLRSLIAQR
MNRIFRENLEFLFDRFESQDLCAVVELEKLIDILKHSHELLSQDLSIDPFSLMLNEMQEN
ISLVSFSSRLATQIWSEMQSDFLPNFILCNTTQRFVRSSKVPPTQKPSVPSAKPSFYCGT
QDLNAAHQSFARLHSGFFGIPHLFSIVKLLGSRSLPWLIRALLDHISNKITTLEPMISGL
QEALPKSIGLLSFDGGVTGCMKLIREQLNWGTKSELKSEVLRGIKEIGSVIYTMGLLDIV
LVSPVRQIVKI*
>AT5G18410.3 | PIR121 transcription activator
MAVPVEEAIAALSTFSLEDEQPEVQGPAVMVSAERAATDSPIEYSDVAAYRLSLSEDTKA
LNQLNTLIQEGKEMASILYTYRSCVKALPQLPESMKHSQADLYLETYQVLDLEMSRLREI
QRWQSSASAKLAADMQRFSRPERRINGPTVTHLWSMLKLLDVLVQLDHLKNAKASIPNDF
SWYKRTFTQVSAQWQDTDTMREELDDLQIFLSTRWAILLNLHVEMFRVNNVEDILQVLIV
FIVESLELDFALLFPERYILLRVLPVLVVLATPSEKDTEALYKRVKLNRLINIFKNDPVI
PAFPDLHLSPAAILKELSVYFQKFSSQTRLLTLPAPHELPPREALEYQRHYLIVNHIGAL
RAEHDDFTIRFASSMNQLLLLKSNDGAYTEWCREVKGNMYDMVVEGFQLLSRWTARIWEQ
CAWKFSRPCRDAGETPEASGSYSDYEKVVRFNYTAEERKALVELVGYIKSVGSMLQRCDT
LVADALWETIHAEVQDFVQNTLATMLRTTFRKKKDLSRILSDMRTLSADWMANTRPEHEM
PSSQHGNDESRGNFFYPRPVAPTAAQVHCLQFLIYEVVSGGNLRRPGGFFGNNGSEIPVN
DLKQLETFFYKLSFFLHILDYSASIGILTDLGFLWFREFYLESSRVIQFPIECSLPWMLI
DYILEAQNSGLLESVLLPFDIYNDSAQQALVVLRQRFLYDEIEAEVDHGFDIFVSRLSES
IFTYYKSWSASELLDPSFLFALDNGEKFSIQPVRFTALFKMTKVKILGRTINLRSLIAQR
MNRIFRENLEFLFDRFESQDLCAVVELEKLIDILKHSHELLSQDLSIDPFSLMLNEMQEN
ISLVSFSSRLATQIWSEMQSDFLPNFILCNTTQRFVRSSKVPPTQKPSVPSAKPSFYCGT
QDLNAAHQSFARLHSGFFGIPHLFSIVKLLGSRSLPWLIRALLDHISNKITTLEPMISGL
QEALPKSIGLLSFDGGVTGCMKLIREQLNWGTKSELKSEVLRGIKEIGSVIYTMGLLDIV
LVSPVRQIVKI*
>AT5G18410.3 | PIR121 transcription activator
MAVPVEEAIAALSTFSLEDEQPEVQGPAVMVSAERAATDSPIEYSDVAAYRLSLSEDTKA
LNQLNTLIQEGKEMASILYTYRSCVKALPQLPESMKHSQADLYLETYQVLDLEMSRLREI
QRWQSSASAKLAADMQRFSRPERRINGPTVTHLWSMLKLLDVLVQLDHLKNAKASIPNDF
SWYKRTFTQVSAQWQDTDTMREELDDLQIFLSTRWAILLNLHVEMFRVNNVEDILQVLIV
FIVESLELDFALLFPERYILLRVLPVLVVLATPSEKDTEALYKRVKLNRLINIFKNDPVI
PAFPDLHLSPAAILKELSVYFQKFSSQTRLLTLPAPHELPPREALEYQRHYLIVNHIGAL
RAEHDDFTIRFASSMNQLLLLKSNDGAYTEWCREVKGNMYDMVVEGFQLLSRWTARIWEQ
CAWKFSRPCRDAGETPEASGSYSDYEKVVRFNYTAEERKALVELVGYIKSVGSMLQRCDT
LVADALWETIHAEVQDFVQNTLATMLRTTFRKKKDLSRILSDMRTLSADWMANTRPEHEM
PSSQHGNDESRGNFFYPRPVAPTAAQVHCLQFLIYEVVSGGNLRRPGGFFGNNGSEIPVN
DLKQLETFFYKLSFFLHILDYSASIGILTDLGFLWFREFYLESSRVIQFPIECSLPWMLI
DYILEAQNSGLLESVLLPFDIYNDSAQQALVVLRQRFLYDEIEAEVDHGFDIFVSRLSES
IFTYYKSWSASELLDPSFLFALDNGEKFSIQPVRFTALFKMTKVKILGRTINLRSLIAQR
MNRIFRENLEFLFDRFESQDLCAVVELEKLIDILKHSHELLSQDLSIDPFSLMLNEMQEN
ISLVSFSSRLATQIWSEMQSDFLPNFILCNTTQRFVRSSKVPPTQKPSVPSAKPSFYCGT
QDLNAAHQSFARLHSGFFGIPHLFSIVKLLGSRSLPWLIRALLDHISNKITTLEPMISGL
QEALPKSIGLLSFDGGVTGCMKLIREQLNWGTKSELKSEVLRGIKEIGSVIYTMGLLDIV
LVSPVRQIVKI*
>AT1G73230.1 | nascent polypeptide-associated complex (NAC) domain-containing protein
MNREKLMKMANTVRTGGKGTVRRKKKAVHKTTTTDDKRLQSTLKRVGVNSIPAIEEVNIF
KDDVVIQFINPKVQASIAANTWVVSGTPQTKKLQDILPQIISQLGPDNLDNLKKLAEQFQ
KQAPGAGDVPATIQEEDDDDDVPDLVVGETFETPATEEAPKAAAS*
>AT3G12390.1 | nascent polypeptide associated complex alpha chain protein putative / alpha-NAC putative
MTTEEKEILAAKLEEQKIDLDKPEVEDDDDNEDDDSDDDDKDDDEADGLDGEAGGKSKQS
RSEKKSRKAMLKLGMKPITGVSRVTVKKSKNILFVISKPDVFKSPASDTYVIFGEAKIED
LSSQIQSQAAEQFKAPDLSNVISKGESSSAAVVQDDEEVDEEGVEPKDIELVMTQAGVSR
PNAVKALKAADGDIVSAIMELTT*
>AT5G17690.1 | TFL2 (TERMINAL FLOWER 2) DNA binding / methylated histone residue binding
MKGASGAVKKKPQVLNEAGEAETAVETVGESRKISGDGGFGSDDGGGGGGGGSGESILRE
IGDDRPTEDGDEEEEEDEDEDDGGDEEDEEGEGEGGQEERPKLDEGFYEIEAIRRKRVRK
GKVQYLIKWRGWPETANTWEPLENLQSIADVIDAFEGSLKPGKPGRKRKRKYAGPHSQMK
KKQRLTSTSHDATEKSDSSTSLNNSSLPDIPDPLDLSGSSLLNRDVEAKNAYVSNQVEAN
SGSVGMARQVRLIDNEKEYDPTLNELRGPVNNSNGAGCSQGGGIGSEGDNVRPNGLLKVY
PKELDKNSRFIGAKRRKSGSVKRFKQDGSTSNNHTAPTDQNLTPDLTTLDSFGRIARMGN
EYPGVMENCNLSQKTKIEELDITKILKPMSFTASVSDNVQEVLVTFLALRSDGKEALVDN
RFLKAHNPHLLIEFYEQHLKYNRTP*
>AT4G34700.1 | complex 1 family protein / LVR family protein
MSGVSTAAYFARRAAQKERVRILYRRALKDTLNWAVHRHIFYRDASDLREKFNVNQDVED
VDRIDKLIAHGEAEYNKWRHPDPYIVPWAPGGSKFCRNPTPPAGIEIVYNYGLEDNP*
>AT5G17550.1 | PEX19-2
MANDTHTDDLDELLDSALDDFKDLNLTQRNGGVKKEEGDKKETESLPSGVQGLGMGLPDM
RSKKKGKKKIAKEDHVTEALDKLREQTRETVKGLESLSSKQQPTGSDDAMVEDWIKQFEN
LTGSNDLESIVDTMMQQLLSKDILHEPMKEIGARYPKWLEEHESSLNKEEFDRYSRQYEL
IKELNLVYENEPNNSTKIMEIMQKMQECGQPPSDIVQEMDPGFDFASLGQMSPDMLESSP
NCCVM*
>AT3G03490.1 | PEX19-1 (peroxin 19-1)
MANSHTDDLDELLDSALDDFKDLNLSHQRNQREAQEEEEKKRKEETVLLPSGVQGLGMGL
PDMRSKKRGKQKVSKEDHVAEALDKLREQTRETVKGLESISSKQLPASDDDGMVEDFLKQ
FEDLAGSKDLESIVETMMQQLLSKDILHEPMKELGARYPKWLKENEASLSKEDYKRYSQQ
YKLIEELNAVYENEPNNSSKIMEIMQKMQECGQPPSDIVKEIDPGFDFASLGQISPEMLE
SSPNCCIM*
>AT2G22290.1 | ATRABH1D (ARABIDOPSIS RAB GTPASE HOMOLOG H1D) GTP binding
MASVSPLAKYKLVFLGDQSVGKTSIITRFMYDKFDTTYQATIGIDFLSKTMYLEDRTVRL
QLWDTAGQERFRSLIPSYIRDSSVAVVVYDVANRLSFLNTSKWIEEVRNERAGDVIIVLV
GNKTDLVEKRQVSIEEGDSKGREYGVMFIETSAKAGFNIKPLFRKIAAALPGMESYSNTK
NEDMVDVNLKPTSNSSQGDQQGGACSC*
>AT5G42970.1 | COP8 (CONSTITUTIVE PHOTOMORPHOGENIC 8) protein binding
MDEALTNASAIGDQRQKIEQYKLILSSVLSSNDLLQAQRFIDHILSDDVPLVVSRQLLQS
FAQELGRLEPETQKEIAQFTLTQIQPRVVSFEEQALVIREKLAGLYESEQEWSKAAQMLS
GIDLDSGMRAVDDNFKLSKCIQIARLYLEDDDAVNAEAFINKASFLVSNSQNEVLNLQYK
VCYARILDMKRKFLEAALRYYGISQIEQRQIGDEEIDENALEQALSAAVTCTILAGAGPQ
RSRVLATLYKDERCSKLKIYPILQKVYLERILRRPEIDAFSEELRPHQKASLPDKSTVLD
RAMIEHNLLSASKLYTNIRFDELGTLLAIDPRKAEKIAANMIGQDRMRGSIDQEEAVIHF
EDDVEELQQWDQQISGLCQALNDILDGMAKKGMSVPV*
>AT4G39100.1 | SHL1 (short life) transcription factor/ zinc-mediated transcriptional activator
MPKQKAPRKQLKSYKLKHINKSIQEGDAVLMRSSEPGKPSYVARVEAIETDARGSHAKVR
VRWYYRPEESIGGRRQFHGAKEVFLSDHFDFQSADTIEGKCKVHSFSSYTKLDSVGNDDF
FCRFEYNSTTGAFDPDRVTVFCKCEMPYNPDDLMVQCEECSEWFHPSCIGTTIEEAKKPD
NFYCEECSPQQQNLHNSNSTSNNRDAKVNGKRSLEVTKSKNKHTKRPG*
>AT5G63860.1 | UVR8 (UVB-RESISTANCE 8) chromatin binding / guanyl-nucleotide exchange factor
MAEDMAADEVTAPPRKVLIISAGASHSVALLSGDIVCSWGRGEDGQLGHGDAEDRPSPTQ
LSALDGHQIVSVTCGADHTVAYSQSGMEVYSWGWGDFGRLGHGNSSDLFTPLPIKALHGI
RIKQIACGDSHCLAVTMEGEVQSWGRNQNGQLGLGDTEDSLVPQKIQAFEGIRIKMVAAG
AEHTAAVTEDGDLYGWGWGRYGNLGLGDRTDRLVPERVTSTGGEKMSMVACGWRHTISVS
YSGALYTYGWSKYGQLGHGDLEDHLIPHKLEALSNSFISQISGGWRHTMALTSDGKLYGW
GWNKFGQVGVGNNLDQCSPVQVRFPDDQKVVQVSCGWRHTLAVTERNNVFAWGRGTNGQL
GIGESVDRNFPKIIEALSVDGASGQHIESSNIDPSSGKSWVSPAERYAVVPDETGLTDGS
SKGNGGDISVPQTDVKRVRI*
>AT5G13850.1 | NACA3 (NASCENT POLYPEPTIDE-ASSOCIATED COMPLEX SUBUNIT ALPHA-LIKE PROTEIN 3)
MTAEQKVELAAKLEEQKIDLDKPEVEDDDDNDEDDSEDDDEAEGHDGEAGGRSKQSRSEK
KSRKAMLKLGMKPITGVSRVTVKKSKNILFVISKPDVFKSPASDTYVIFGEAKIEDLSSQ
LQSQAAEQFKAPNLSNVISQGETSSAATAAAVQDDDDEEVDEEGVEPKDIELVMTQAGVS
KPRAVKALKLANGDIVSAIMELTT*
>AT5G39440.1 | SnRK13 (SNF1-RELATED PROTEIN KINASE 13) ATP binding / kinase/ protein kinase/ protein serine/threonine kinase
MDGSSEKTTNKLVSILPNYRIGKTLGHGSFAKVKLALHVATGHKVAIKILNRSKIKNMGI
EIKVQREIKILRFLMHPHIIRQYEVIETPNDIYVVMEYVKSGELFDYIVEKGKLQEDEAR
HLFQQIISGVEYCHRNMIVHRDLKPENVLLDSQCNIKIVDFGLSNVMHDGHFLKTSCGSP
NYAAPEVISGKPYGPDVDIWSCGVILYALLCGTLPFDDENIPNVFEKIKRGMYTLPNHLS
HFARDLIPRMLMVDPTMRISITEIRQHPWFNNHLPLYLSIPPLDTIDQAKKIEEEIIQNV
VNIGFDRNHVVDSLANRIQNEATVAYHLILDNRNQNSVPNDPFQSKFKEISDGIFNSTLP
VQNITSHVGHSFSALYGLKSNVKDDKTWTLGLQSQGSPYDIMTEIFKALQNLKICWKKIG
LYNIKCRWVRSFAYYKNHTIEDECAIILPTVIKFEIQLYKVREGKYLLDILRIDGPQFIF
FDLCVAFLRELGVL*
>AT3G48470.1 | EMB2423 (EMBRYO DEFECTIVE 2423)
MAEGTKQERTLENNLLHKVGEAVSAISDAKHVDQVISAIHSVAVLLFPVDPSLFSGNFEM
LHIVRGSGTFGLLMILYLGSAQVCSSVVPSADERNEWLETFYRGVAFPTFARVLLLDVAS
DWLSCFPISVQKHLYDKFFLDGSVIEVVQVLVPFLHHVGDGGVNANSVQTNVERLLILCL
LENDGVLKITKEIGNIYQGHNSSNGSLKPLLSRLSQILTSIPDKARASCTEANCTVIVLS
FVGEVFSRICRRGLSDLLLSEVTPHVLAQVRRLLNSKIGAIEVDTFQLDPTTRIWSKTME
AVTDPYAVEKMAEQLLHQLYAEHPSDVEAFWTIWTLFHRNVIHQASVRQAKCFLWQLDSF
FRYPFFFFHFHPNAVKQCVLECPPVTNTLAKGDVTQGLLETTQRLASVWSKREFLQSVQL
EQQAYLQFLFPVTDISDITAALGLCLENMSREELDRTKDVMHSILQGVSCRLENPGDLVR
KMASSIAFMFSKVIDPKNPLYLDDSITDNAIDWEFGLQTASITNTMENGDGENKRSASLT
EVNESSRRNKQKENRKSKNISAFVLADPNEIVDLATLNCDTESDKDDGDDDASVSSDNSS
VTSLEPYDLMDDDKDLGKQFTHLVDVVGALRKTDDADGVEKAIYVAEKLVRASPDELTHI
AGDLARTLVQVRCSDIAIEGEEDSAEEKRQRALIALLVTRPFESLETLNNILYSPNVDVS
QRIMILDVMAEAARELANSKTLKPKHEARGPLISNISDPQPWYLPSNASTPWKKVSETGS
FHLNWANRFERELQSKPGQTKKGKSRRWSLKSADRDQNSTDWSQNRFPLYAAAFMLPAMK
EFDKKRHGVDLLGRDFVVLGKLVHMLGVCMQCASMHPEASALAISLLDMLQRREVCNHPE
AYVRRAVLFAASSVLVSLHPSYIVSTLVEGNLDLSRALEWIRTWALQIADSDIDRDCYTM
ALSCLQLHAEMALQTSRALESTGGSSSSSSIRPMNISLPSGISKLTSIKLPSSNVHL*
>AT1G03910.1 | EXPRESSED IN 25 plant structures EXPRESSED DURING 13 growth stages CONTAINS InterPro DOMAIN/s Cactin central region (InterProIPR018816) BEST Arabidopsis thaliana protein match is unknown protein (TAIRAT2G368152) Has 11516 Blast hits to 6722 proteins in 356 species Archae - 23 Bacteria - 259 Metazoa - 6122 Fungi - 1009 Plants - 493 Viruses - 33 Other Eukaryotes - 3577 (source NCBI BLink)
MGSHGKGKRDRSGRQKKRRDESESGSESESYTSDSDGSDDLSPPRSSRRKKGSSSRRTRR
RSSSDDSSDSDGGRKSKKRSSSKDYSEEKVTEYMSKKAQKKALRAAKKLKTQSVSGYSND
SNPFGDSNLTETFVWRKKIEKDVHRGVPLEEFSVKAEKRRHRERMTEVEKVKKRREERAV
EKARHEEEMALLARERARAEFHDWEKKEEEFHFDQSKVRSEIRLREGRLKPIDVLCKHLD
GSDDLDIELSEPYMVFKGLTVKDMEELRDDIKMYLDLDRATPTRVQYWEALIVVCDWELA
EARKRDALDRARVRGEEPPAELLAQERGLHAGVEADVRKLLDGKTHAELVELQLDIESQL
RSGSAKVVEYWEAVLKRLEIYKAKACLKEIHAEMLRRHLHRLEQLSEGEDDVEVNPGLTR
VVEENEEEINDTNLSDAEEAFSPEPVAEEEEADEAAEAAGSFSPELMHGDDREEAIDPEE
DKKLLQMKRMIVLEKQKKRLKEAMDSKPAPVEDNLELKAMKAMGAMEEGDAIFGSNAEVN
LDSEVYWWHDKYRPRKPKYFNRVHTGYEWNKYNQTHYDHDNPPPKIVQGYKFNIFYPDLV
DKIKAPIYTIEKDGTSAETCMIRFHAGPPYEDIAFRIVNKEWEYSHKKGFKCTFERGILH
LYFNFKRHRYRR*
>AT2G14045.1 | unknown protein
MMRYKEEKEVKKEAFRKYLESSGVLDSLTKVLVSLYEQNDKPSSALEFIQQKLGGPSVSD
YEKLQAEKSDLQIKYNELLAKHQETLRELNGVKSLHSRNSSKDDADRETLEAEHTTLVTP
HH*
>AT2G14045.1 | unknown protein
MMRYKEEKEVKKEAFRKYLESSGVLDSLTKVLVSLYEQNDKPSSALEFIQQKLGGPSVSD
YEKLQAEKSDLQIKYNELLAKHQETLRELNGVKSLHSRNSSKDDADRETLEAEHTTLVTP
HH*
>AT2G14045.2 | unknown protein
MMRYKEEKEVKKEAFRKYLESSGVLDSLTKVLVSLYEQNDKPSSALEFIQQKLGGPSVSD
YEKLQAEKSDLQIKYNELLAKHQETLRELNGVKSLHSRNSSKDDADRETLEAEHTTLVTP
HH*
>AT2G14045.2 | unknown protein
MMRYKEEKEVKKEAFRKYLESSGVLDSLTKVLVSLYEQNDKPSSALEFIQQKLGGPSVSD
YEKLQAEKSDLQIKYNELLAKHQETLRELNGVKSLHSRNSSKDDADRETLEAEHTTLVTP
HH*
>AT5G47080.1 | CKB1 protein kinase regulator
MYRDRGTVNSRPEVVDRKRINDALERPSPSTSRQVNGKGKGTVTAATTTANLIGKQQSNN
INHRDSRSASLSKNNTVSDDESDTDSEESDVSGSDGEDTSWISWFCNLRGNEFFCEVDDD
YIQDDFNLCGLSSLVPYYEYALDLILDVESSQGEMFTEEQNELIESAAEMLYGLIHARYI
LTSKGLAAMLDKYKNYDFGRCPRVYCCGQPCLPVGQSDLPRSSTVKIYCPKCEDIYYPRS
KYQGNIDGAYFGTTFPHLFLMTYGHLKPAKATQNYVQRVFGFKLHKP*
>AT5G47080.1 | CKB1 protein kinase regulator
MYRDRGTVNSRPEVVDRKRINDALERPSPSTSRQVNGKGKGTVTAATTTANLIGKQQSNN
INHRDSRSASLSKNNTVSDDESDTDSEESDVSGSDGEDTSWISWFCNLRGNEFFCEVDDD
YIQDDFNLCGLSSLVPYYEYALDLILDVESSQGEMFTEEQNELIESAAEMLYGLIHARYI
LTSKGLAAMLDKYKNYDFGRCPRVYCCGQPCLPVGQSDLPRSSTVKIYCPKCEDIYYPRS
KYQGNIDGAYFGTTFPHLFLMTYGHLKPAKATQNYVQRVFGFKLHKP*
>AT5G47080.1 | CKB1 protein kinase regulator
MYRDRGTVNSRPEVVDRKRINDALERPSPSTSRQVNGKGKGTVTAATTTANLIGKQQSNN
INHRDSRSASLSKNNTVSDDESDTDSEESDVSGSDGEDTSWISWFCNLRGNEFFCEVDDD
YIQDDFNLCGLSSLVPYYEYALDLILDVESSQGEMFTEEQNELIESAAEMLYGLIHARYI
LTSKGLAAMLDKYKNYDFGRCPRVYCCGQPCLPVGQSDLPRSSTVKIYCPKCEDIYYPRS
KYQGNIDGAYFGTTFPHLFLMTYGHLKPAKATQNYVQRVFGFKLHKP*
>AT5G47080.2 | CKB1 protein kinase regulator
MYRDRGTVNSRPEVVDRKRINDALERPSPSTSRQVNGKGKGTVTAATTTANLIGKQQSNN
INHRDSRSASLSKNNTVSDDESDTDSEESDVSGSDGEDTSWISWFCNLRGNEFFCEVDDD
YIQDDFNLCGLSSLVPYYEYALDLILDVESSQGEMFTEEQNELIESAAEMLYGLIHARYI
LTSKGLAAMLDKYKNYDFGRCPRVYCCGQPCLPVGQSDLPRSSTVKIYCPKCEDIYYPRS
KYQGSILFSTVSLLLI*
>AT5G47080.2 | CKB1 protein kinase regulator
MYRDRGTVNSRPEVVDRKRINDALERPSPSTSRQVNGKGKGTVTAATTTANLIGKQQSNN
INHRDSRSASLSKNNTVSDDESDTDSEESDVSGSDGEDTSWISWFCNLRGNEFFCEVDDD
YIQDDFNLCGLSSLVPYYEYALDLILDVESSQGEMFTEEQNELIESAAEMLYGLIHARYI
LTSKGLAAMLDKYKNYDFGRCPRVYCCGQPCLPVGQSDLPRSSTVKIYCPKCEDIYYPRS
KYQGSILFSTVSLLLI*
>AT5G47080.2 | CKB1 protein kinase regulator
MYRDRGTVNSRPEVVDRKRINDALERPSPSTSRQVNGKGKGTVTAATTTANLIGKQQSNN
INHRDSRSASLSKNNTVSDDESDTDSEESDVSGSDGEDTSWISWFCNLRGNEFFCEVDDD
YIQDDFNLCGLSSLVPYYEYALDLILDVESSQGEMFTEEQNELIESAAEMLYGLIHARYI
LTSKGLAAMLDKYKNYDFGRCPRVYCCGQPCLPVGQSDLPRSSTVKIYCPKCEDIYYPRS
KYQGSILFSTVSLLLI*
>AT5G47080.3 | CKB1 protein kinase regulator
MYRDRGTVNSRPEVVDRKRINDALERPSPSTSRQVNGKGKGTVTAATTTANLIGKQQSNN
INHRDSRSASLSKNNTVSDDTDSEESDVSGSDGEDTSWISWFCNLRGNEFFCEVDDDYIQ
DDFNLCGLSSLVPYYEYALDLILDVESSQGEMFTEEQNELIESAAEMLYGLIHARYILTS
KGLAAMLDKYKNYDFGRCPRVYCCGQPCLPVGQSDLPRSSTVKIYCPKCEDIYYPRSKYQ
GSILFSTVSLLLI*
>AT5G47080.3 | CKB1 protein kinase regulator
MYRDRGTVNSRPEVVDRKRINDALERPSPSTSRQVNGKGKGTVTAATTTANLIGKQQSNN
INHRDSRSASLSKNNTVSDDTDSEESDVSGSDGEDTSWISWFCNLRGNEFFCEVDDDYIQ
DDFNLCGLSSLVPYYEYALDLILDVESSQGEMFTEEQNELIESAAEMLYGLIHARYILTS
KGLAAMLDKYKNYDFGRCPRVYCCGQPCLPVGQSDLPRSSTVKIYCPKCEDIYYPRSKYQ
GSILFSTVSLLLI*
>AT5G47080.3 | CKB1 protein kinase regulator
MYRDRGTVNSRPEVVDRKRINDALERPSPSTSRQVNGKGKGTVTAATTTANLIGKQQSNN
INHRDSRSASLSKNNTVSDDTDSEESDVSGSDGEDTSWISWFCNLRGNEFFCEVDDDYIQ
DDFNLCGLSSLVPYYEYALDLILDVESSQGEMFTEEQNELIESAAEMLYGLIHARYILTS
KGLAAMLDKYKNYDFGRCPRVYCCGQPCLPVGQSDLPRSSTVKIYCPKCEDIYYPRSKYQ
GSILFSTVSLLLI*
>AT1G66950.1 | PDR11 (PLEIOTROPIC DRUG RESISTANCE 11) ATPase coupled to transmembrane movement of substances
MAAMLGRDEDPVGALSGRVSLASTSHRSLVGASKSFRDVFMPQTDEVFGRSERREEDDME
LRWAAIERLPTFDRLRKGMLPQTSANGKIELEDIDLTRLEPKDKKHLMEMILSFVEEDNE
KFLRDLRERTDRVGIEVPKIEVRYENISVEGDVRSASRALPTLFNVTLNTLESILGFFHL
LPSKRKKIQILKDISGIVKPSRMTLLLGPPSSGKTTLLQALAGKLDDTLQMSGRITYCGH
EFREFVPQKTCAYISQHDLHFGEMTVREILDFSGRCLGVGSRYQLMSELSRREKEEGIKP
DPKIDAFMKSIAISGQETSLVTDYVLKILGLDICADILAGDVMRRGISGGQKKRLTTGEM
LVGPARALFMDEISTGLDSSTTFQICKFMRQLVHISDVTMIISLLQPAPETFELFDDIIL
LSEGQIVYQGPRDNVLEFFEYFGFQCPERKGVADFLQEVTSKKDQEQYWNKREQPYNYVS
VSDFSSGFSTFHTGQKLTSEFRVPYDKAKTHSAALVTQKYGISNWELFKACFDREWLLMK
RNSFVYVFKTVQITIMSLITMTVYLRTEMHVGTVRDGQKFYGAMFFSLINVMFNGLAELA
FTVMRLPVFYKQRDFLFYPPWAFALPAWLLKIPLSLIESGIWIGLTYYTIGFAPSAARFF
RQLLAYFCVNQMALSLFRFLGAIGRTEVISNSIGTFTLLIVFTLGGFIIAKDDIRPWMTW
AYYMSPMMYGQTAIVMNEFLDERWSSPNYDTRINAKTVGEVLLKSRGFFTEPYWFWICIV
ALLGFSLLFNLFYILALMYLNPLGNSKATVVEEGKDKQKGENRGTEGSVVELNSSSNKGP
KRGMVLPFQPLSLAFNNVNYYVDMPSEMKAQGVEGDRLQLLRDVGGAFRPGILTALVGVS
GAGKTTLMDVLAGRKTGGYIEGSISISGYPKNQTTFARVSGYCEQNDIHSPHVTVYESLI
YSAWLRLSTDIDIKTRELFVEEVMELVELKPLRNSIVGLPGVDGLSTEQRKRLTIAVELV
ANPSIIFMDEPTSGLDARAAAIVMRTVRNTVDTGRTVVCTIHQPSIDIFESFDELLLMKR
GGQVIYAGSLGHHSQKLVEYFEAVEGVPKINDGYNPATWMLDVTTPSMESQMSLDFAQIF
SNSSLYRRNQELIKDLSTPPPGSKDVYFKTKYAQSFSTQTKACFWKQYWSYWRHPQYNAI
RFLMTVVIGVLFGLIFWQIGTKTENEQDLNNFFGAMYAAVLFLGALNAATVQPAIAIERT
VFYREKAAGMYSAIPYAISQVAVEIMYNTIQTGVYTLILYSMIGCNWTMAKFLWFYYYML
TSFIYFTLYGMMLMALTPNYQIAGICMSFFLSLWNLFSGFLIPRPQIPIWWRWYYWATPV
AWTLYGLITSQVGDKDSMVHISGIGDIDLKTLLKEGFGFEHDFLPVVAVVHIAWILLFLF
VFAYGIKFLNFQRR*
>AT3G16700.1 | fumarylacetoacetate hydrolase family protein
MATSMIQRLFKQGTKIVGVGLNYASHAKELGNALPKDPIVFLKPTSSYLENGGTIEIPHP
LDSLHHEVELAVVIGQKARDVPERLAMNYIGGYALALDMTARELQVSAMASGLPCTLAKG
QDTFTPISSVLPKAMVLDPNNLELWLKVDDETRQKGWTKDMIFKVPYLISYISSVMTLFK
GDVILTGTPEGIGPVKIGQKITAGITGLSEVQFDVGRRLKPLLR*
>AT3G16700.1 | fumarylacetoacetate hydrolase family protein
MATSMIQRLFKQGTKIVGVGLNYASHAKELGNALPKDPIVFLKPTSSYLENGGTIEIPHP
LDSLHHEVELAVVIGQKARDVPERLAMNYIGGYALALDMTARELQVSAMASGLPCTLAKG
QDTFTPISSVLPKAMVLDPNNLELWLKVDDETRQKGWTKDMIFKVPYLISYISSVMTLFK
GDVILTGTPEGIGPVKIGQKITAGITGLSEVQFDVGRRLKPLLR*
>AT3G16700.2 | fumarylacetoacetate hydrolase family protein
MATSMIQRLFKQGTKIVGVGLNYASHAKELGNALPKDPIVFLKPTSSYLENGGTIEIPHP
LDSLHHEVELAVVIGQKARDVPERLAMNYIGGYALALDMTARELQVSAMASGLPCTLAKG
QDTFTPISSVLPKAMVLDPNNLELWLKVWLLMLSCHKLRCSLLESPITGR*
>AT3G16700.2 | fumarylacetoacetate hydrolase family protein
MATSMIQRLFKQGTKIVGVGLNYASHAKELGNALPKDPIVFLKPTSSYLENGGTIEIPHP
LDSLHHEVELAVVIGQKARDVPERLAMNYIGGYALALDMTARELQVSAMASGLPCTLAKG
QDTFTPISSVLPKAMVLDPNNLELWLKVWLLMLSCHKLRCSLLESPITGR*
>AT1G47490.2 | ATRBP47C (ARABIDOPSIS THALIANA RNA-BINDING PROTEIN 47C) RNA binding
MADVKIQSESESSDSHPVVDNQPPPPPPPPQQPAKEEENQPKTSPTPPPHWMRYPPTVII
PHQMMYAPPPFPPYHQYPNHHHLHHQSRGNKHQNAFNGENKTIWVGDLHHWMDEAYLNSS
FASGDEREIVSVKVIRNKNNGLSEGYGFVEFESHDVADKVLREFNGTTMPNTDQPFRLNW
ASFSTGEKRLENNGPDLSIFVGDLSPDVSDNLLHETFSEKYPSVKAAKVVLDANTGRSKG
YGFVRFGDENERTKAMTEMNGVKCSSRAMRIGPATPRKTNGYQQQGGYMPNGTLTRPEGD
IMNTTVIVFP*
>AT1G47490.2 | ATRBP47C (ARABIDOPSIS THALIANA RNA-BINDING PROTEIN 47C) RNA binding
MADVKIQSESESSDSHPVVDNQPPPPPPPPQQPAKEEENQPKTSPTPPPHWMRYPPTVII
PHQMMYAPPPFPPYHQYPNHHHLHHQSRGNKHQNAFNGENKTIWVGDLHHWMDEAYLNSS
FASGDEREIVSVKVIRNKNNGLSEGYGFVEFESHDVADKVLREFNGTTMPNTDQPFRLNW
ASFSTGEKRLENNGPDLSIFVGDLSPDVSDNLLHETFSEKYPSVKAAKVVLDANTGRSKG
YGFVRFGDENERTKAMTEMNGVKCSSRAMRIGPATPRKTNGYQQQGGYMPNGTLTRPEGD
IMNTTVIVFP*
>AT1G47490.1 | ATRBP47C (ARABIDOPSIS THALIANA RNA-BINDING PROTEIN 47C) RNA binding
MADVKIQSESESSDSHPVVDNQPPPPPPPPQQPAKEEENQPKTSPTPPPHWMRYPPTVII
PHQMMYAPPPFPPYHQYPNHHHLHHQSRGNKHQNAFNGENKTIWVGDLHHWMDEAYLNSS
FASGDEREIVSVKVIRNKNNGLSEGYGFVEFESHDVADKVLREFNGTTMPNTDQPFRLNW
ASFSTGEKRLENNGPDLSIFVGDLSPDVSDNLLHETFSEKYPSVKAAKVVLDANTGRSKG
YGFVRFGDENERTKAMTEMNGVKCSSRAMRIGPATPRKTNGYQQQGGYMPNGTLTRPEGD
IMNTTIFVGGLDSSVTDEDLKQPFNEFGEIVSVKIPVGKGCGFVQFVNRPNAEEALEKLN
GTVIGKQTVRLSWGRNPANKQPRDKYGNQWVDPYYGGQFYNGYGYMVPQPDPRMYPAAPY
YPMYGGHQQQVS*
>AT1G47490.1 | ATRBP47C (ARABIDOPSIS THALIANA RNA-BINDING PROTEIN 47C) RNA binding
MADVKIQSESESSDSHPVVDNQPPPPPPPPQQPAKEEENQPKTSPTPPPHWMRYPPTVII
PHQMMYAPPPFPPYHQYPNHHHLHHQSRGNKHQNAFNGENKTIWVGDLHHWMDEAYLNSS
FASGDEREIVSVKVIRNKNNGLSEGYGFVEFESHDVADKVLREFNGTTMPNTDQPFRLNW
ASFSTGEKRLENNGPDLSIFVGDLSPDVSDNLLHETFSEKYPSVKAAKVVLDANTGRSKG
YGFVRFGDENERTKAMTEMNGVKCSSRAMRIGPATPRKTNGYQQQGGYMPNGTLTRPEGD
IMNTTIFVGGLDSSVTDEDLKQPFNEFGEIVSVKIPVGKGCGFVQFVNRPNAEEALEKLN
GTVIGKQTVRLSWGRNPANKQPRDKYGNQWVDPYYGGQFYNGYGYMVPQPDPRMYPAAPY
YPMYGGHQQQVS*
>AT1G33040.1 | NACA5 (NASCENT POLYPEPTIDE-ASSOCIATED COMPLEX SUBUNIT ALPHA-LIKE PROTEIN 5)
MPGAIVEEEKSQIESIKEQLKLEKEDDVVVEDVKDGEEEDDDEDDEDVEVEGEGGNENAK
QSRSEKKSRKAVLKLGMKPVSDVSRVTIKRAKNVLFVISKPDVYKSPNAETYVIFGEAKV
DDLSSQLQTQAAQRFKMPDVTSMLPNAGSEATMAPLAEEEDEDDVDDTGVEARDIDLVMT
QAGVSKAKAVSALKANDGDIVSAIMELTT*
>AT2G23080.2 | casein kinase II alpha chain putative
MSKARVYTDVNVVRPKEYWDYESLVVQWGHQDDYEVVRKVGRGKYSEVFEGKNVNTNERC
VIKILKPVKKKKIKREIKILQNLCGGPNIVKLYDIVRDEHSKTPSLVFEFVNSVDFKVLY
PTLTDYDIRYYIYELLKALDFCHSQGIMHRDVKPHNVMIDHQLRKLRLIDWGLAEFYHPG
KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI
AKVLGTNELDHYLNKYQLDLDPQLEALVGRHVPKPWSKFINADNQHLVSPEVLLFFEKHS
FASFWVY*
>AT2G23080.2 | casein kinase II alpha chain putative
MSKARVYTDVNVVRPKEYWDYESLVVQWGHQDDYEVVRKVGRGKYSEVFEGKNVNTNERC
VIKILKPVKKKKIKREIKILQNLCGGPNIVKLYDIVRDEHSKTPSLVFEFVNSVDFKVLY
PTLTDYDIRYYIYELLKALDFCHSQGIMHRDVKPHNVMIDHQLRKLRLIDWGLAEFYHPG
KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI
AKVLGTNELDHYLNKYQLDLDPQLEALVGRHVPKPWSKFINADNQHLVSPEVLLFFEKHS
FASFWVY*
>AT2G23080.1 | casein kinase II alpha chain putative
MSKARVYTDVNVVRPKEYWDYESLVVQWGHQDDYEVVRKVGRGKYSEVFEGKNVNTNERC
VIKILKPVKKKKIKREIKILQNLCGGPNIVKLYDIVRDEHSKTPSLVFEFVNSVDFKVLY
PTLTDYDIRYYIYELLKALDFCHSQGIMHRDVKPHNVMIDHQLRKLRLIDWGLAEFYHPG
KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI
AKVLGTNELDHYLNKYQLDLDPQLEALVGRHVPKPWSKFINADNQHLVSPEAIDFLDKLL
QYDHQDRLTAREAMDHPYFAQVKAAESSRLRTQ*
>AT2G23080.1 | casein kinase II alpha chain putative
MSKARVYTDVNVVRPKEYWDYESLVVQWGHQDDYEVVRKVGRGKYSEVFEGKNVNTNERC
VIKILKPVKKKKIKREIKILQNLCGGPNIVKLYDIVRDEHSKTPSLVFEFVNSVDFKVLY
PTLTDYDIRYYIYELLKALDFCHSQGIMHRDVKPHNVMIDHQLRKLRLIDWGLAEFYHPG
KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI
AKVLGTNELDHYLNKYQLDLDPQLEALVGRHVPKPWSKFINADNQHLVSPEAIDFLDKLL
QYDHQDRLTAREAMDHPYFAQVKAAESSRLRTQ*
>AT1G17130.1 | cell cycle control protein-related
MGERKVLNKYYPPDFDPAKLQRLRRPKNQQIKVRMMLPMSVRCGTCGNYIYKGTKFNSRK
EDVIGETYLGIQIFRFYFKCTKCSAELTMKTDPQNSDYIVESGASRNYEPWRAEDEEVDK
DKQKRDAEEMGDAMKSLENRTLDSKREMDIIAALDEMKSMKSRHATVSVDAMLEALQRTG
AEKVKRIEEEDEAVIKSIFGKQKEVIRRIADEEIDDDYDDDDIDDYPSLQKEKKGSSSDL
SKKRKATEVSPSNPTDILTSSSAENPKEPKKQAISKQPFKSVHIKVIKKQPQPTSSSTPA
PAKPEEKKSDGAANTSLASLFQNYGSDEDED*
>AT1G17130.1 | cell cycle control protein-related
MGERKVLNKYYPPDFDPAKLQRLRRPKNQQIKVRMMLPMSVRCGTCGNYIYKGTKFNSRK
EDVIGETYLGIQIFRFYFKCTKCSAELTMKTDPQNSDYIVESGASRNYEPWRAEDEEVDK
DKQKRDAEEMGDAMKSLENRTLDSKREMDIIAALDEMKSMKSRHATVSVDAMLEALQRTG
AEKVKRIEEEDEAVIKSIFGKQKEVIRRIADEEIDDDYDDDDIDDYPSLQKEKKGSSSDL
SKKRKATEVSPSNPTDILTSSSAENPKEPKKQAISKQPFKSVHIKVIKKQPQPTSSSTPA
PAKPEEKKSDGAANTSLASLFQNYGSDEDED*
>AT1G17130.2 | cell cycle control protein-related
MGERKVLNKYYPPDFDPAKLQRLRRPKNQQIKVRMMLPMSVRCGTCGNYIYKGTKFNSRK
EDVIGENFSFDVQTYLGIQIFRFYFKCTKCSAELTMKTDPQNSDYIVESGASRNYEPWRA
EDEEVDKDKQKRDAEEMGDAMKSLENRTLDSKREMDIIAALDEMKSMKSRHATVSVDAML
EALQRTGAEKVKRIEEEDEAVIKSIFGKQKEVIRRIADEEIDDDYDDDDIDDYPSLQKEK
KGSSSDLSKKRKATEVSPSNPTDILTSSSAENPKEPKKQAISKQPFKSVHIKVIKKQPQP
TSSSTPAPAKPEEKKSDGAANTSLASLFQNYGSDEDED*
>AT1G17130.2 | cell cycle control protein-related
MGERKVLNKYYPPDFDPAKLQRLRRPKNQQIKVRMMLPMSVRCGTCGNYIYKGTKFNSRK
EDVIGENFSFDVQTYLGIQIFRFYFKCTKCSAELTMKTDPQNSDYIVESGASRNYEPWRA
EDEEVDKDKQKRDAEEMGDAMKSLENRTLDSKREMDIIAALDEMKSMKSRHATVSVDAML
EALQRTGAEKVKRIEEEDEAVIKSIFGKQKEVIRRIADEEIDDDYDDDDIDDYPSLQKEK
KGSSSDLSKKRKATEVSPSNPTDILTSSSAENPKEPKKQAISKQPFKSVHIKVIKKQPQP
TSSSTPAPAKPEEKKSDGAANTSLASLFQNYGSDEDED*